IL157649A0 - Adenosine derivatives having an acetylene group in the 4' position, pharmaceutical compositions containing them and use thereof in decreasing plasma free fatty acid concentration - Google Patents

Adenosine derivatives having an acetylene group in the 4' position, pharmaceutical compositions containing them and use thereof in decreasing plasma free fatty acid concentration

Info

Publication number: IL157649A0
Authority: IL; Israel
Prior art keywords: fatty acid; pharmaceutical compositions; compositions containing; acid concentration; free fatty
Prior art date: 2001-03-20

Application number

IL15764902A

Other languages

English (en)

Original Assignee

Glaxo Group Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-03-20

Filing date

2002-03-19

Publication date

2004-05-12

2001-03-20 Priority claimed from GB0106875A external-priority patent/GB0106875D0/en

2001-03-20 Priority claimed from GB0106877A external-priority patent/GB0106877D0/en

2001-03-20 Priority claimed from GB0106871A external-priority patent/GB0106871D0/en

2002-03-19 Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd

2004-05-12 Publication of IL157649A0 publication Critical patent/IL157649A0/xx

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
- C07D473/32—Nitrogen atom
- C07D473/34—Nitrogen atom attached in position 6, e.g. adenine

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
General Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Diabetes (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Biotechnology (AREA)
Biochemistry (AREA)
Molecular Biology (AREA)
Genetics & Genomics (AREA)
Hematology (AREA)
Pain & Pain Management (AREA)
Hospice & Palliative Care (AREA)
Obesity (AREA)
Anesthesiology (AREA)
Rheumatology (AREA)
Otolaryngology (AREA)
Emergency Medicine (AREA)
Endocrinology (AREA)
Vascular Medicine (AREA)
Urology & Nephrology (AREA)
Pulmonology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

IL15764902A 2001-03-20 2002-03-19 Adenosine derivatives having an acetylene group in the 4' position, pharmaceutical compositions containing them and use thereof in decreasing plasma free fatty acid concentration IL157649A0 (en)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
GB0106875A GB0106875D0 (en)	2001-03-20	2001-03-20	Medicaments
GB0106877A GB0106877D0 (en)	2001-03-20	2001-03-20	Chemical compounds
GB0106871A GB0106871D0 (en)	2001-03-20	2001-03-20	Chemical compounds
PCT/GB2002/001317 WO2002074780A1 (en)	2001-03-20	2002-03-19	Chemical compounds

Publications (1)

Publication Number	Publication Date
IL157649A0 true IL157649A0 (en)	2004-05-12

Family

ID=27256108

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IL15764902A IL157649A0 (en)	2001-03-20	2002-03-19	Adenosine derivatives having an acetylene group in the 4' position, pharmaceutical compositions containing them and use thereof in decreasing plasma free fatty acid concentration

Country Status (18)

Country	Link
US (1)	US20040162422A1 (es)
EP (1)	EP1370568B1 (es)
JP (1)	JP2004534002A (es)
KR (1)	KR20030085014A (es)
CN (1)	CN1501941A (es)
AR (1)	AR037135A1 (es)
AT (1)	ATE306492T1 (es)
BR (1)	BR0208169A (es)
CA (1)	CA2441202A1 (es)
CZ (1)	CZ20032543A3 (es)
DE (1)	DE60206605D1 (es)
HU (1)	HUP0303533A3 (es)
IL (1)	IL157649A0 (es)
MX (1)	MXPA03008493A (es)
NO (1)	NO20034182L (es)
NZ (1)	NZ527854A (es)
PL (1)	PL364712A1 (es)
WO (1)	WO2002074780A1 (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
KR20050067384A (ko) *	2002-08-15	2005-07-01	씨브이 쎄러퓨틱스, 인코포레이티드	부분적 또는 완전한 ａ1 아데노신 수용체의 작용제
GB0221694D0 (en) *	2002-09-18	2002-10-30	Glaxo Group Ltd	Compounds
GT200500281A (es) *	2004-10-22	2006-04-24	Novartis Ag	Compuestos organicos.
GB0500785D0 (en)	2005-01-14	2005-02-23	Novartis Ag	Organic compounds
GB0607953D0 (en) *	2006-04-21	2006-05-31	Novartis Ag	Organic compounds
RU2457209C2 (ru) *	2006-04-21	2012-07-27	Новартис Аг	Производные пурина, предназначенные для применения в качестве агонистов аденозинового рецептора а2а
GB0607950D0 (en) *	2006-04-21	2006-05-31	Novartis Ag	Organic compounds
GB0607945D0 (en) *	2006-04-21	2006-05-31	Novartis Ag	Organic compounds
GB0607948D0 (en) *	2006-04-21	2006-05-31	Novartis Ag	Organic compounds
GB0607944D0 (en) *	2006-04-21	2006-05-31	Novartis Ag	Organic compounds
EP1889846A1 (en)	2006-07-13	2008-02-20	Novartis AG	Purine derivatives as A2a agonists
EP1903044A1 (en) *	2006-09-14	2008-03-26	Novartis AG	Adenosine Derivatives as A2A Receptor Agonists
RU2009121819A (ru) *	2006-11-10	2010-12-20	Новартис АГ (CH)	Производные моноацетата циклопентендиола
KR20100068286A (ko) *	2007-10-17	2010-06-22	노파르티스 아게	아데노신 ａ1 수용체 리간드로서의 퓨린 유도체

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4996308A (en) *	1988-03-25	1991-02-26	Merrell Dow Pharmaceuticals Inc.	Derivatives with unsaturated substitutions for the 5'-hydroxymethyl group
GB9723589D0 (en) *	1997-11-08	1998-01-07	Glaxo Group Ltd	Chemical compounds
YU44900A (sh) *	1998-01-31	2003-01-31	Glaxo Group Limited	Derivati 2-(purin-9-il)tetrahidrofuran-3,4-diola
GB9813554D0 (en) *	1998-06-23	1998-08-19	Glaxo Group Ltd	Chemical compounds

2002
- 2002-03-12 US US10/471,681 patent/US20040162422A1/en not_active Abandoned
- 2002-03-19 PL PL02364712A patent/PL364712A1/xx not_active Application Discontinuation
- 2002-03-19 MX MXPA03008493A patent/MXPA03008493A/es unknown
- 2002-03-19 AR ARP020100976A patent/AR037135A1/es not_active Application Discontinuation
- 2002-03-19 JP JP2002573789A patent/JP2004534002A/ja not_active Withdrawn
- 2002-03-19 CN CNA028067754A patent/CN1501941A/zh active Pending
- 2002-03-19 NZ NZ527854A patent/NZ527854A/en unknown
- 2002-03-19 HU HU0303533A patent/HUP0303533A3/hu unknown
- 2002-03-19 EP EP02714332A patent/EP1370568B1/en not_active Expired - Lifetime
- 2002-03-19 AT AT02714332T patent/ATE306492T1/de not_active IP Right Cessation
- 2002-03-19 BR BR0208169-5A patent/BR0208169A/pt not_active Application Discontinuation
- 2002-03-19 KR KR10-2003-7012208A patent/KR20030085014A/ko not_active Withdrawn
- 2002-03-19 CA CA002441202A patent/CA2441202A1/en not_active Abandoned
- 2002-03-19 DE DE60206605T patent/DE60206605D1/de not_active Expired - Lifetime
- 2002-03-19 CZ CZ20032543A patent/CZ20032543A3/cs unknown
- 2002-03-19 WO PCT/GB2002/001317 patent/WO2002074780A1/en not_active Ceased
- 2002-03-19 IL IL15764902A patent/IL157649A0/xx unknown
2003
- 2003-09-19 NO NO20034182A patent/NO20034182L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
NZ527854A (en)	2004-09-24
HUP0303533A3 (en)	2005-02-28
NO20034182D0 (no)	2003-09-19
KR20030085014A (ko)	2003-11-01
DE60206605D1 (de)	2006-02-23
CZ20032543A3 (en)	2004-05-12
BR0208169A (pt)	2004-03-02
US20040162422A1 (en)	2004-08-19
AR037135A1 (es)	2004-10-27
ATE306492T1 (de)	2005-10-15
MXPA03008493A (es)	2003-12-08
EP1370568B1 (en)	2005-10-12
JP2004534002A (ja)	2004-11-11
HUP0303533A2 (hu)	2004-03-01
CN1501941A (zh)	2004-06-02
NO20034182L (no)	2003-09-19
EP1370568A1 (en)	2003-12-17
PL364712A1 (en)	2004-12-13
WO2002074780A1 (en)	2002-09-26
CA2441202A1 (en)	2002-09-26

Publication	Publication Date	Title
HUP0200308A3 (en)	2003-03-28	Quinolinecarboxamides as antiviral agents, pharmaceutical compositions containing them and their use
IL157731A0 (en)	2004-03-28	Caboxylic acid derivatives and pharmaceutical compositions containing the same
HUP0300207A3 (en)	2005-07-28	1,2,3,4-tetrahydroisquinoline derivatives, pharmaceutical compositions containing them and their preparation processes
HUP0103641A3 (en)	2002-10-28	Antiviral purine derivatives, pharmaceutical compositions containing them and their use
IL159086A0 (en)	2004-05-12	3-aryl-5-aryl- [1, 2, 4] -oxadiazole derivatives and pharmaceutical compositions containing the same
IL160716A0 (en)	2004-08-31	Aryl-substituted pyridinecarboxamide derivatives and pharmaceutical compositions containing the same
IL161616A0 (en)	2004-09-27	Indazolypyrrolotriazine derivatives and pharmaceutical compositions containing the same
IL156354A0 (en)	2004-01-04	Pyridoindole derivatives and pharmaceutical compositions containing the same
IL192937A0 (en)	2009-02-11	Pharmaceutical compositions containing beta-lapachone or derivatives or analogs thereof, and methods of using same
HUP0401567A3 (en)	2005-06-28	Novel 4,5-dyhydro-1h-pyrazole derivatives having cb1-antagonistic activity, their use and pharmaceutical compositions containing them
HUP0302997A3 (en)	2004-03-29	Phenylalanine derivatives with alpha4-integrin effect, pharmaceutical compositions containing them and their use
IL158300A0 (en)	2004-05-12	Bisarylimidazol derivatives and pharmaceutical compositions containing the same
HUP0400467A3 (en)	2012-08-28	2-iminopyrrolidine derivatives, pharmaceutical compositions containing them and their use
HUP0400837A3 (en)	2007-11-28	2-phenyl-thiazole derivatives, their use and pharmaceutical compositions containing them
HUP0204474A3 (en)	2004-07-28	1h-imidazopyridine derivatives, pharmaceutical compositions containing them and their use
IL176005A0 (en)	2006-10-05	2,6-bisheteroaryl-4-aminopyrimidine derivatives and pharmaceutical compositions containing the same
IL150224A0 (en)	2002-12-01	Lipopeptides and pharmaceutical compositions containing the same
IL155196A0 (en)	2003-11-23	Benzamide derivatives and pharmaceutical compositions containing the same
PL362177A1 (en)	2004-10-18	Glucopyranosyloxybenzylbenzene derivatives and medicinal compositions containing the same
IL150223A0 (en)	2002-12-01	Lipopeptides and pharmaceutical compositions containing the same
IL161431A0 (en)	2004-09-27	beta-PHENYL-alpha-OXYSUBSTITUTED PROPIONIC ACID DERIVATIVES, PROCESS FOR THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
HUP0102453A3 (en)	2002-10-28	Adenosine derivatives, their use and pharmaceutical compositions containing the compounds
AU2002306269A1 (en)	2003-05-15	N-arylphenylacetamide derivatives and pharmaceutical composition containing the same
HUP0102766A2 (hu)	2001-12-28	Aminometilkarbonsavszármazékok, gyógyászati alkalmazásuk és ilyen vegyületeket tartalmazó gyógyászati készítmények
IL156812A0 (en)	2004-02-08	Phthalazinone-piperidino derivatives and pharmaceutical compositions containing the same